One study demonstrated that restoration of caspase-3 expression, in caspase-3 deficient MCF-7 breast cancer cells, can sensitise to doxorubicin- and etoposide-induced apoptosis, suggesting caspase-3 deficiency may be a possible mechanism for chemoresistance [10, 11]. Here, CASP3 is linked to breast carcinoma.